Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies.
$23.09 0.00 (0.00%)
As of 01/27/2023 11:06:18 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.